Elon Musk’s medical start-up, Neuralink, is planning to conduct clinical trials with its brain implant, according to job postings. The brain-computer interface has been in development since 2016 and is intended to treat various injuries and illnesses, such as enabling people with spinal cord injuries to walk again. While the brain chip has only been tested on animals, Neuralink demonstrated its capabilities in 2020 with a pig and in 2021 with a monkey playing Pong through thought control. The company had originally planned to conduct clinical trials with humans in 2020, but a recent job posting for a clinical trials manager suggests that the first experiments with human subjects could begin in the coming months.
Neuralink’s brain implant has the potential to revolutionize medical treatment for people with spinal cord injuries and other conditions. The implant allows nerve signals to be transmitted to a computer, which can then visualize and interpret them. The company’s demonstrations with animals have shown promising results, and the upcoming clinical trials with humans could be a significant step forward in the development of this technology.
Elon Musk has expressed his excitement about the potential of Neuralink to restore full body function to people with spinal cord injuries. The company’s focus on this area of medical treatment could have a significant impact on the lives of millions of people around the world. As the company moves forward with its clinical trials, it will be important to ensure that the technology is safe and effective for human use. With the right approach, Neuralink’s brain implant could be a game-changer in the field of medical technology.
